Autolus Therapeutics PLC Overview
Company Headquarters: UK, Europe
Founded: 2014
Company Working: Autolus Therapeutics PLC (Autolus), a biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 for the treatment of multiple myeloma; AUTO4 and AUTO 5 for T cell lymphoma; and AUTO6 and AUTO7 to treat solid tumors. The company functions as a single operating segment, which is the business of developing and commercializing gene therapies.
Strategy
Autolus . aims to be at the forefront of cancer treatment in the coming years by diversifying its product portfolio. Moreover, the company focuses on following value-based and ethical healthcare principles to attract new customers and drive global growth. The company also focuses on collaborations with industry partners having complementary technologies and capabilities to strengthen its position in the market in the upcoming years.



